March 2023—Assessing cardiac allograft rejection from endomyocardial biopsy​ and assigning a differential diagnosis to cancers of unknown origin have been shown to get a boost from AI-driven computational pathology models. So too has identifying subregions of high diagnostic value on whole slide images.
Read More »